Related references
Note: Only part of the references are listed.Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium model
Bernadett Boda et al.
ANTIVIRAL RESEARCH (2018)
Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings
Hiroki Koshimichi et al.
CLINICAL DRUG INVESTIGATION (2018)
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
Nick S. Laursen et al.
SCIENCE (2018)
Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
Rameshwar U. Kadam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Potent peptidic fusion inhibitors of influenza virus
Rameshwar U. Kadam et al.
SCIENCE (2017)
Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA
Shanshan Lang et al.
CELL REPORTS (2017)
An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and-resistant influenza A viruses
Yanmei Hu et al.
ANTIVIRAL RESEARCH (2017)
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
M. Gordon Joyce et al.
CELL (2016)
Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
Nicole L. Kallewaard et al.
CELL (2016)
Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design
Wen-Chun Liu et al.
JOURNAL OF VIROLOGY (2016)
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
Erin Sparrow et al.
VACCINE (2016)
Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine
Alice Cho et al.
CURRENT OPINION IN VIROLOGY (2016)
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
Merika Treants Koday et al.
PLOS PATHOGENS (2016)
Stalking influenza by vaccination with pre-fusion headless HA mini-stem
Sophie A. Valkenburg et al.
SCIENTIFIC REPORTS (2016)
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Hadi M. Yassine et al.
NATURE MEDICINE (2015)
Flexibility and small pockets at protein-protein interfaces: New insights into druggability
Harry Jubb et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2015)
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Antonietta Impagliazzo et al.
SCIENCE (2015)
A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus
Ying Wu et al.
NATURE COMMUNICATIONS (2015)
Antiviral strategies against influenza virus: towards new therapeutic approaches
Arianna Loregian et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
CH-π T-Shape Interaction with Histidine Explains Binding of Aromatic Galactosides to Pseudomonas aeruginosa Lectin LecA
Rameshwar U. Kadam et al.
ACS CHEMICAL BIOLOGY (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization
Boerries Brandenburg et al.
PLOS ONE (2013)
Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
Mayo Yasugi et al.
PLOS PATHOGENS (2013)
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Damian C. Ekiert et al.
NATURE (2012)
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
Timothy A. Whitehead et al.
NATURE BIOTECHNOLOGY (2012)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
Dennis R. Burton et al.
SCIENCE (2012)
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
Julie E. Ledgerwood et al.
LANCET INFECTIOUS DISEASES (2011)
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
James R. R. Whittle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
Sarel J. Fleishman et al.
SCIENCE (2011)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
Gayathri Bommakanti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Protein-protein docking benchmark version 4.0
Howook Hwang et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus
Rui Xu et al.
SCIENCE (2010)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
Suitability of PER.C6® cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics
W. Koudstaal et al.
VACCINE (2009)
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
Mark Throsby et al.
PLOS ONE (2008)
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
Arun K. Kashyap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inference of macromolecular assemblies from crystalline state
Evgeny Krissinel et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Antiviral agents active against influenza A viruses
Erik De Clercq
NATURE REVIEWS DRUG DISCOVERY (2006)
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants
Natalia A. Ilyushina et al.
ANTIVIRAL RESEARCH (2006)
Likelihood-enhanced fast translation functions
AJ McCoy et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus
J Stevens et al.
SCIENCE (2004)
HI and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes
RJ Russell et al.
VIROLOGY (2004)
Antiviral therapy for influenza - A clinical and economic comparative review
AC Schmidt
DRUGS (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
PHENIX:: building new software for automated crystallographic structure determination
PD Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes
Y Ha et al.
EMBO JOURNAL (2002)
Share Paper
